Hiroomi Watabe
- Co-authors
- Minako AraakeK. MorikawaShigeru MorikawaTakehiko ShibataTadahiko AndoMasaji SezakiTAKASHI SHOMURAShinichi Kondo
- Topics
- Microbial Natural Products and Biosynthesis (7 papers)Antibiotic Resistance in Bacteria (6 papers)Cancer therapeutics and mechanisms (5 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroomi Watabe
27 papers receiving 556 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 292
- Pharmacology 164
- Epidemiology 95
- Organic Chemistry 81
- Immunology 80
Countries citing papers authored by Hiroomi Watabe
This map shows the geographic impact of Hiroomi Watabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroomi Watabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroomi Watabe more than expected).
Fields of papers citing papers by Hiroomi Watabe
This network shows the impact of papers produced by Hiroomi Watabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroomi Watabe. The network helps show where Hiroomi Watabe may publish in the future.
Co-authorship network of co-authors of Hiroomi Watabe
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroomi Watabe. A scholar is included among the top collaborators of Hiroomi Watabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroomi Watabe. Hiroomi Watabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | [Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins]. | 3 |
| 3 | 16 | |
| 4 | [Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa]. | 3 |
| 5 | [In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone]. | 3 |
| 6 | 11 | |
| 7 | 0 | |
| 8 | 11 | |
| 9 | 4 | |
| 10 | 178 | |
| 11 | 27 | |
| 12 | 13 | |
| 13 | 13 | |
| 14 | 18 | |
| 15 | 42 | |
| 16 | A new antibiotic SF2583A, 4-chloro-5-(3'-indolyl)oxazole, produced by Streptomyces. | 13 |
| 17 | 28 | |
| 18 | 35 | |
| 19 | 53 | |
| 20 | 17 |
About Hiroomi Watabe
Hiroomi Watabe is a scholar working on Microbiology, Molecular Medicine and Pharmacology, having authored 28 papers that have together received 590 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Pharmacology (164 citations), Molecular Medicine (46 citations) and Toxicology (25 citations). Hiroomi Watabe has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Minako Araake, K. Morikawa, Shigeru Morikawa, Takehiko Shibata, Tadahiko Ando, Masaji Sezaki, TAKASHI SHOMURA, Shinichi Kondo, T Iino and HARUO YAMAMOTO. Their work appears in journals such as Nature, Journal of Biological Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.